First Trust Advisors
BIVV

First Trust Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Trust Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-767,277
Closed -$41.4M – 2458
2017
Q4 		$41.4M Buy
767,277
+97,250
+15% +$5.32M 0.1% 245
2017
Q3 		$38.2M Buy
670,027
+586,885
+706% +$34.4M 0.1% 237
2017
Q2 		$5M Buy
83,142
+9,705
+13% +$553K 0.01% 1026
2017
Q1 		$4M Buy
+73,437
New +$3.62M 0.01% 1135

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Trust Advisors's BIVV Position: Q1 2018 in Review

First Trust Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 767,277 shares — an estimated $41.4M sold.

First Trust Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $41.4M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • First Trust Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • First Trust Advisors sold 767,277 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $41.4M.
  • First Trust Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • First Trust Advisors's Bioverativ Inc. Common Stock position peaked at $41.4M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Trust Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.